(Q30485092)

14 October 2017

2 references

1 July 2020

25 October 2022

An overview of triple infection with hepatitis B, C and D viruses (English)

1 reference

14 October 2017

1 reference

1 July 2020

3 references

23 March 2019

21 March 2019

1 July 2020

3 references

23 March 2019

21 March 2019

1 July 2020

2

Muhamad Idrees

1 reference

14 October 2017

Mehwish Riaz

1

1 reference

14 October 2017

Hifza Kanwal

series ordinal

3

1 reference

14 October 2017

Firoz Kabir

series ordinal

4

1 reference

14 October 2017

language of work or name

1 reference

27 July 2011

5 references

14 October 2017

23 March 2019

21 March 2019

1 July 2020

25 October 2022

5 references

14 October 2017

23 March 2019

21 March 2019

1 July 2020

25 October 2022

8

1 reference

14 October 2017

368

1 reference

Creative Commons Attribution 2.0 Generic

14 October 2017

4 references

23 March 2019

21 March 2019

1 July 2020

on focus list of Wikimedia project

25 October 2022

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

Introduction to chronic hepatitis B infection

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

Multiple viral infections

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

Comparative analysis of intracellular trans-splicing ribozyme activity against hepatitis C virus internal ribosome entry site.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

Diagnosis, management, and treatment of hepatitis C

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

High prevalence of antibodies to hepatitis A and E viruses and viremia of hepatitis B, C, and D viruses among apparently healthy populations in Mongolia.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

Kinetics of the immune response during HBV and HCV infection.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

Immune responses in hepatitis B virus infection

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

The large delta antigen of hepatitis delta virus potently inhibits genomic but not antigenomic RNA synthesis: a mechanism enabling initiation of viral replication

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

Clinical and virological course of chronic hepatitis B virus infection with hepatitis C and D virus markers

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

Transmission of hepatitis C virus: rates, routes, and cofactors

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

Hepatocellular carcinoma: pathogenetic implications of the hepatitis delta virus.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

Prevalence and significance of hepatitis C viremia in chronic active hepatitis B.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

The role of hepatitis C virus in fulminant viral hepatitis in an area with endemic hepatitis A and B.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

The interaction between hepatitis B virus and hepatitis C virus in acute and chronic liver disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

Role of hepatitis C virus in dual and triple hepatitis virus infection

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

To C or not to C: these are the questions.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

Delta hepatitis--present status.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

Systemic distribution of woodchuck hepatitis virus in the tissues of experimentally infected woodchucks

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

Use of animal models to study hepatitis B virus

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

Prevalence of anti-HCV antibodies in patients with chronic liver disease and its relationship to HBV and HDV infections

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

Hepatitis C Virus Infection in Chronic Hepatitis B Virus Carriers

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

Role of hepatitis delta virus infection in hepatocellular carcinoma.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

The significance of antibody to hepatitis C virus in patients with chronic hepatitis B.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan

20 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-8-368

High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-8-368

Role of hepatitis C and delta viruses in the termination of chronic hepatitis B surface antigen carrier state: a multivariate analysis in a longitudinal follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-8-368

The long-term course of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-8-368

The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-8-368

Coinfection of hepatitis C virus in patients with chronic hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-8-368

Characteristics of patients with dual infection by hepatitis B and C viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-8-368

Tracing hepatitis C and Delta viruses to estimate their contribution in HCC rates in Mongolia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-8-368

High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-8-368

Detection of serum hepatitis B, C, and D viral nucleic acids and its implications in hepatocellular carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-8-368

A simple, rapid, and sensitive integrated protein microarray for simultaneous detection of multiple antigens and antibodies of five human hepatitis viruses (HBV, HCV, HDV, HEV, and HGV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-8-368

Interference between non-A, non-B and hepatitis B virus infection in chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-8-368

Suppression of hepatitis C virus (HCV) replication by hepatitis D virus (HDV) in HIV-infected hemophiliacs with chronic hepatitis B and C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-8-368

Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-8-368

Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-8-368

Clearance of chronic HCV infection during acute delta hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-8-368

Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-8-368

Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-8-368

Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-8-368

Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-8-368

Triple hepatitis: frequency and treatment outcome of co/super-infection of hepatitis C and D among patients of hepatitis B.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

General seroprevalence of hepatitis C and hepatitis B virus infections in population

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatic infections

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

Multiple viral infection as the most common cause of fulminant and subfulminant viral hepatitis in an area endemic for hepatitis B: application and limitations of the polymerase chain reaction

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156777

Lamivudine for chronic delta hepatitis

26 November 2018

1 reference

12 December 2020

1 reference

12 December 2020

Frequency and comparative analysis of hapatitis D in petients seeking treatment for hepatitis B

1 reference

12 December 2020

Role of molecular techniques in the detection of HBV DNA & HCV RNA among renal transplant recipients in India

1 reference

12 December 2020

Clinical course and consequences of hepatitis B infection

1 reference

12 December 2020

Clinical and virologic outcomes of hepatitis B and C viral coinfection after liver transplantation: effect of viral hepatitis D

1 reference

12 December 2020

Natural history of compensated viral B and D cirrhosis

1 reference

12 December 2020

Global status of hepatitis B immunisation

1 reference

12 December 2020

Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment

1 reference

12 December 2020

Treatment of chronic hepatitis D: New advances, old challenges

1 reference

12 December 2020

Identifiers

DOI

10.1186/1743-422X-8-368

1 reference

Dimensions Publication ID

14 October 2017

0 references

1 reference

14 October 2017

PubMed publication ID

21791115

1 reference